Dee Dee Wang, M.D., FACC, FSCAI, FASE, FSCCT specializes in Interventional Imaging in Structural Heart Interventions including Transcatheter mitral valve replacement therapies, tricuspid interventions, mitral e-clip, complex TAVRs/adult-congenital cases, LAA interventions, and ASD/PFO closures. Dr. Wang is clinically subspecialized in developing and teaching 2D/3D TEE based imaging guided device therapy techniques and protocols for new technologies, and innovating 3D and 4D CT based peri-procedural planning protocols for high risk interventions. Dr. Wang’s research interests are focused on advancing patient safety and procedural outcomes utilizing 3D+4D imaging for high-risk Structural Heart Interventions. She is an Associate Professor at Wayne State University, Director of Structural Heart Imaging at Henry Ford Hospital’s Center for Structural Heart Disease, Medical Director of 3D Printing at Henry Ford Innovations Institute, and Director of the CT and Echo CoreLab at Henry Ford Hospital’s Center for Structural Heart Disease. Contributions Dee Dee Wang, MD, FSCAI SCAI/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure (LAAC) Dee Dee Wang, MD, FSCAI Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID‐19 Pandemic: An ACC/SCAI Position Statement